Cc Peptide

Lab Reagents

Cc Laboratories manufactures the cc peptide reagents distributed by Genprice. The Cc Peptide reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Cc. Other Cc products are available in stock. Specificity: Cc Category: Peptide

Lab Tools information

CC-90003
B2419-5	Biovision	each	EUR 496.8

CC-115
B2499-25	Biovision	each	EUR 757.2

CC-115
B2499-5	Biovision	each	EUR 235.2

Lenalidomide (CC-5013)
A4211-100	ApexBio	100 mg	EUR 226.8
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects.

Lenalidomide (CC-5013)
A4211-250	ApexBio	250 mg	EUR 268.8
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects.

Lenalidomide (CC-5013)
A4211-5.1	ApexBio	10 mM (in 1mL DMSO)	EUR 135.6
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects.

Lenalidomide (CC-5013)
A4211-50	ApexBio	50 mg	EUR 184.8
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects.

Lenalidomide (CC-5013)
A4211-500	ApexBio	500 mg	EUR 309.6
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects.

Lenalidomide (CC-5013)
A4211-S	ApexBio	Evaluation Sample	EUR 97.2
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects.

Pomalidomide (CC-4047)
A4212-10	ApexBio	10 mg	EUR 170.4
Description: Pomalidomide, previously known as CC-4047 or actimid, is a potent immunomodulatory molecule that exhibits antineoplastic activity for the treatment of hematological malignancies, especially relapsed and refractory multiple myeloma (MM).

Pomalidomide (CC-4047)
A4212-200	ApexBio	200 mg	EUR 964.8
Description: Pomalidomide, previously known as CC-4047 or actimid, is a potent immunomodulatory molecule that exhibits antineoplastic activity for the treatment of hematological malignancies, especially relapsed and refractory multiple myeloma (MM).

Pomalidomide (CC-4047)
A4212-5	ApexBio	5 mg	EUR 129.6
Description: Pomalidomide, previously known as CC-4047 or actimid, is a potent immunomodulatory molecule that exhibits antineoplastic activity for the treatment of hematological malignancies, especially relapsed and refractory multiple myeloma (MM).

Pomalidomide (CC-4047)
A4212-5.1	ApexBio	10 mM (in 1mL DMSO)	EUR 135.6
Description: Pomalidomide, previously known as CC-4047 or actimid, is a potent immunomodulatory molecule that exhibits antineoplastic activity for the treatment of hematological malignancies, especially relapsed and refractory multiple myeloma (MM).

Pomalidomide (CC-4047)
A4212-50	ApexBio	50 mg	EUR 351.6
Description: Pomalidomide, previously known as CC-4047 or actimid, is a potent immunomodulatory molecule that exhibits antineoplastic activity for the treatment of hematological malignancies, especially relapsed and refractory multiple myeloma (MM).

Pomalidomide (CC-4047)
A4212-S	ApexBio	Evaluation Sample	EUR 97.2
Description: Pomalidomide, previously known as CC-4047 or actimid, is a potent immunomodulatory molecule that exhibits antineoplastic activity for the treatment of hematological malignancies, especially relapsed and refractory multiple myeloma (MM).

Apremilast (CC-10004)
A4317-10	ApexBio	10 mg	EUR 268.8
Description: Apremilast, also known as CC-10004, is a novel and potent small-molecule inhibitor of phosphodiesterase 4 (PDE4), a key enzyme involved in cyclic adenosine monophosphate (cAMP) degradation and cytokine production of inflammatory cells.

Apremilast (CC-10004)
A4317-25	ApexBio	25 mg	EUR 338.4
Description: Apremilast, also known as CC-10004, is a novel and potent small-molecule inhibitor of phosphodiesterase 4 (PDE4), a key enzyme involved in cyclic adenosine monophosphate (cAMP) degradation and cytokine production of inflammatory cells.